Orchestra BioMed Holdings Inc Sustainability Reports

Orchestra BioMed Holdings, Inc. is a biomedical innovation company focused on developing high-impact therapeutic technologies for patients with major medical needs. Its flagship programs include atrioventricular interval modulation therapy for hypertension and heart failure, and sirolimus angioinfusion balloon treatments for vascular diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG00W5FR3L1

No reports are currently available in our catalogue.